iData Insights

Extremity Reconstruction - South American Analysis and Market Forecasts Is Released

Press Release   •   Feb 26, 2016 13:57 IST

The growing aging population, rising prevalence of arthritis, and expanding indications for extremity implant devices, as well as patient preference to maintain an active lifestyle, are expected to drive growth in the extremity replacement market through the forecast period. Emerging extremity implant technologies focus on recreating patient anatomy and natural joint function. Additionally, manufacturers focus on less invasive implant designs to accommodate future revision procedures. This report examines extremity implant device adoption and challenges faced by current competitors in the extremity reconstruction market in Brazil. The analysis also identifies unmet needs in the market, specifies the major drivers and barriers to device adoption, provides insight into marketed and pipeline products, and provides an understanding of physician perception and outlook with an overall emphasis on current and future industry trends in Brazil. *This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.

Highlights Key Questions Answered - What is the current and future extremity reconstruction market outlook in Brazil? What trends are affecting this market? - Which are the key, high growth markets that extremity implant manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment? - What are the unmet needs with extremity reconstruction products currently on the market? How will emerging technologies fulfill these unmet needs? - What clinical factors and technical specifications influence a physician to use one implant device over another? What is physician perception and market outlook of extremity reconstruction? - What are the challenges and complications of extremity reconstruction that have hindered widespread adoption? - With developing the next-generation of extremity implant products, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the Brazilian extremity reconstruction market? Scope - Annualized total extremity reconstruction market revenue by type of device, direct and indirect costs of disease, procedure trends, and market outlooks in Brazil through 2021. - Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in Brazil, and implications of the emerging technologies on the market. - Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and extremity implant products in development. - Analysis of the current and future market competition in the Brazilian extremity reconstruction market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications. Reasons to buy - What Physicians Thinkquotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading orthopedic surgeons from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Browse Complete Report with TOC @

To Get Sample Copy of Report visit @

Table of Contents

3 Introduction

3.1 Catalyst

3.2 Related Reports

4 Industry Overview

4.1 Overview

4.2 Procedure Trends

4.2.1 By Country

4.3 Market Access

4.3.1 Purchasing Decisions

4.3.2 Adoption

4.4 Brand Loyalty

4.5 Regulation

4.5.1 South America

4.6 Reimbursement

4.6.1 South America

4.7 Product Recalls

4.8 Mergers and Acquisitions

4.8.1 Wright Medical Merges with Tornier in $3.3 Billion All-Stock Deal (October 2015)

4.8.2 Integra LifeSciences to Acquire Total Ankle Replacement Portfolio from Tornier N.V. (September 2015)

4.8.3 Zimmer Acquires Biomet in $13.35 Billion Deal (June 2015)

4.8.4 Teijin Acquires Nakashima Medical for JPY 1.5 Billion (April 2015)

4.8.5 Stryker Acquires Small Bone Innovations for $375m (August-September 2014)

4.8.6 Wright Medical Acquires OrthoPro for $36m (February 2014)

4.8.7 Wright Medical Acquires Solana Surgical for $90m (January 2014)

4.8.8 Wright Medical Acquires Biotech International for $80m (November 2013)

4.8.9 Johnson & Johnson Acquires Synthes for $19.7 Billion (June 2012)

4.8.10 Integra LifeSciences Acquires Ascension Orthopedics for $65m (September 2011)

4.9 Economic Impact

4.9.1 Arthritis

4.9.2 High Revision Rates

5 Unmet Needs

5.1 Shoulder Replacement

5.1.1 Durable Glenoid Components

5.1.2 Augmented Glenoid Components

5.1.3 Grammont-Style Versus Frankle-Style

5.1.4 Addressing Complications of Reverse Shoulder Replacement

5.1.5 Bone-Sparing Stemless Designs: Pros and Cons

5.1.6 Revision Systems

5.1.7 Long-Term Follow-Up

5.1.8 Patient Awareness in Emerging Markets

5.1.9 Accurate Glenoid Component Positioning

5.1.10 Implant Sizing for APAC Patients

5.2 Elbow Replacement

5.2.1 Implant Survival and Fixation Techniques

5.2.2 Implant Positioning

5.2.3 Long-Term Follow-Up

5.3 Wrist Replacement

5.3.1 Long-Term Clinical Data

5.3.2 Limited Product Offerings

5.3.3 Failure and Revision Rates

5.3.4 Physiological Wrist Movement

5.3.5 Carpal Component Fixation

5.4 Digits Replacement

5.4.1 Pyrocarbon Implant Durability and Fixation

5.4.2 Improved Patient Functionality

5.5 Ankle Replacement

5.5.1 Long-Term Follow-Up

5.5.2 Commitment to Medical Education

5.5.3 Advanced Biological Fixation

5.5.4 Minimal Bone Resection

5.5.5 Mobile-Bearing Versus Fixed-Bearing

5.5.6 Bespoke Instrumentation

5.5.7 Custom Prostheses

5.5.8 Revision Components

6 Market Drivers, Barriers, and Opportunities

6.1 Driver: Rising Joint Disease Prevalence

6.1.1 Sport-Related Injuries

6.1.2 Trauma

6.1.3 Aging

6.1.4 Obesity

6.2 Driver: Increased Patient Awareness

6.3 Driver: Corporate Promotions and Continuing Medical Education

6.4 Driver: Expected Launch of CE-Marked Devices

6.5 Driver: Expanded Indications of Reverse Shoulder Replacement

6.6 Driver: Stemless Shoulder Implants in the EU

6.7 Driver: Superiority of Ankle Replacment over Ankle Fusion

6.8 Driver: Expanded Insurance Coverage for TAR

6.9 Barrier: Medical Device Excise Tax

6.10 Barrier: Postoperative Complications

6.11 Barrier: Long Learning Curve

6.12 Barrier: Alternatives to Total Joint Replacement

6.13 Barrier: Shoulder Replacement Reimbursement

6.14 Barrier: Preoperative Patient Selection for TAR

6.15 Opportunity: Pyrocarbon

6.16 Opportunity: Demand for a Comprehensive Reconstruction Portfolio

6.17 Opportunity: Computer-Assisted Navigation and Patient-Specific Instrumentation

6.18 Opportunity: Emerging Markets

6.19 Opportunity: Capitalizing on Wrist Market Fragmentation

6.20 Opportunity: TAR Expanded Indications

6.21 Opportunity: Fixed-Bearing TAR Implants in the EU

7 Competitive Assessment

7.1 Shoulder Replacement

7.1.1 Overview

7.1.2 Product Profiles - Anatomic Total Shoulder Replacement

7.1.3 Product Profiles - Anatomic Stemless Total Shoulder Replacement

7.1.4 Product Profiles - Reverse Total Shoulder Replacement

7.2 Elbow Replacement

7.2.1 Overview

7.2.2 Product Profiles

7.3 Wrist Replacement

7.3.1 Overview

7.3.2 Product Profiles

7.4 Digits Replacement

7.4.1 Overview

7.4.2 Product Profiles

7.5 Ankle Replacement

7.5.1 Overview

7.5.2 Product Profiles - Two-Component Fixed-Bearing

7.5.3 Product Profiles - Three-Component Mobile-Bearing

8 Pipeline Assessment

8.1 Overview

8.2 Product Profiles

8.2.1 AFT Proximal Humerus Fracture Prosthesis (Shoulder Options)

8.2.2 Akilos Total Ankle System (Implants International)

8.2.3 aSpire Total Shoulder Arthroplasty System (Shoulder Options)

8.2.4 Comprehensive Nano Stemless Shoulder (Zimmer Biomet)

8.2.5 Helical Conservative Shoulder Prosthesis (University of Missouri)

8.2.6 INBONE Calcaneal Stem Implant (Wright Medical)

8.2.7 Luna Stemless Humeral Prosthesis (Shoulder Options)

8.2.8 PyroCarbon Modular Radial Head (Integra LifeSciences)

8.2.9 NDSU Total Ankle Replacement Device (NDSU Research Foundation)

8.2.10 Vantage Ankle System (Exactech)

9 Clinical Trials to Watch

9.1 Overview

9.2 Discovery Elbow Long-Term Survivorship Study

9.3 Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Reverse Shoulder System

9.4 An Observational Cohort Study Evaluating the Safety and Performance of Aequalis Resurfacing Head Implant in a Consecutive Series of Patients with Shoulder Arthroplasty

9.5 Sidus(TM) Stem-Free Shoulder - A Multi-center, Prospective, Non-controlled Post Market Clinical Follow-up Study

9.6 A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrexs Eclipse Shoulder Prosthesis to the Univers II Shoulder Prosthesis in Patients with a Degenerative Joint Disease

9.7 Prospective Post Market Clinical Follow-Up (PMCF) Study of the Zimmer Trabecular Metal Total Ankle

9.8 Motec Versus Remotion Total Wrist Arthroplasty - A Prospective Randomized Study

9.9 A Post-market Clinical Follow-up Study of the TITAN Reverse Shoulder System Used in Primary or Revision Total Shoulder Arthroplasty

9.10 A Prospective Multi-Center Study of the Safety and Effectiveness of the Tornier Simpliciti Shoulder System in Shoulder Arthroplasty

9.11 Retrospective and Prospective Clinical Outcomes Study of the Zimmer Nexel Total Elbow

10 Current and Future Players

10.1 Overview

10.2 Trends in Corporate Strategy

10.3 Acumed

10.3.1 Overview

10.3.2 Portfolio Assessment

10.3.3 SWOT Analysis

10.4 Arthrex

10.4.1 Overview

10.4.2 Portfolio Assessment

10.4.3 SWOT Analysis

10.5 Corin Group

10.5.1 Overview

10.5.2 Portfolio Assessment

10.5.3 SWOT Analysis

10.6 DePuy Synthes (Johnson & Johnson)

10.6.1 Overview

10.6.2 Portfolio Assessment

10.6.3 SWOT Analysis

10.7 DJO Global

10.7.1 Overview

10.7.2 Portfolio Assessment

10.7.3 SWOT Analysis

10.8 Exactech

10.8.1 Overview

10.8.2 Portfolio Assessment

10.8.3 SWOT Analysis

10.9 Integra LifeSciences

10.9.1 Overview

10.9.2 Portfolio Assessment

10.9.3 SWOT Analysis

10.10 Kyocera Medical Corporation

10.10.1 Overview

10.10.2 Portfolio Assessment

10.10.3 SWOT Analysis

10.11 Lima Corporate

10.11.1 Overview

10.11.2 Portfolio Assessment

10.11.3 SWOT Analysis

10.12 Smith & Nephew

10.12.1 Overview

10.12.2 Portfolio Assessment

10.12.3 SWOT Analysis

10.13 Stryker

10.13.1 Overview

10.13.2 Portfolio Assessment

10.13.3 SWOT Analysis

10.14 Tornier

10.14.1 Overview

10.14.2 Portfolio Assessment

10.14.3 SWOT Analysis

10.15 Wright Medical Group

10.15.1 Overview

10.15.2 Portfolio Assessment

10.15.3 SWOT Analysis

10.16 Zimmer Biomet Holdings

10.16.1 Overview

10.16.2 Portfolio Assessment

10.16.3 SWOT Analysis

10.17 Other Players

11 Market Outlook

11.1 Company Market Share

11.1.1 By Region

11.2 By Geography

11.2.1 Brazil

12 Appendix

12.1 Bibliography

12.2 Abbreviations

12.3 Methodology

12.3.1 Overview

12.3.2 Coverage

12.3.3 Secondary Research

12.4 Forecasting Methodology

12.5 Physicians and Specialists Included in This Study

12.5.1 Key Opinion Leaders

12.6 Primary Research Summary

12.7 About the Authors

12.7.1 Analysts

12.7.2 Global Head of Medical Devices

12.8 About GlobalData

12.9 Contact Us

12.10 Disclaimer

Read More

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

iData Insights

Tel: 1-866-237-2965


AboutiData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects